Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Targeted Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07504939
What this trial is testing

Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma

Who this might be right for
Upper Tract Urothelial Carcinoma Receiving Kidney-sparing TherapyUpper Tract Urothelial Carcinoma
Peking University First Hospital 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04739800
What this trial is testing

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Who this might be right for
Fallopian Tube Mucinous AdenocarcinomaOvarian Seromucinous CarcinomaPlatinum-Refractory Fallopian Tube Carcinoma+47 more
National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Study completedNCT00846456
What this trial is testing

Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

Who this might be right for
GlioblastomaBrain Tumor
Oslo University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00889057
What this trial is testing

Sorafenib in Relapsed High Grade Osteosarcoma

Who this might be right for
Osteosarcoma
Italian Sarcoma Group 35
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Not applicableLooking for participantsNCT02290522
What this trial is testing

Copenhagen Prospective Personalized Oncology (CoPPO)

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Ulrik Lassen 500
Testing effectiveness (Phase 2)Study completedNCT05538195
What this trial is testing

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+2 more
Chongqing Precision Biotech Co., Ltd 17
Early research (Phase 1)Looking for participantsNCT06313957
What this trial is testing

LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed B-cell Non-Hodgkin LymphomaRefractory B-cell Non-Hodgkin Lymphoma
Peking University Cancer Hospital & Institute 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04625647
What this trial is testing

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Who this might be right for
Lung AdenocarcinomaLung Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+3 more
SWOG Cancer Research Network 116
Testing effectiveness (Phase 2)UnknownNCT05163249
What this trial is testing

Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Guangdong Association of Clinical Trials 44
Early research (Phase 1)Active Not RecruitingNCT06342908
What this trial is testing

A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma

Who this might be right for
Diffuse Hemispheric Glioma, H3 G34-Mutant
Jonsson Comprehensive Cancer Center 6
Not applicableStudy completedNCT02346708
What this trial is testing

Cognitive Dysfunction in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Colorado, Denver 49
Testing effectiveness (Phase 2)Looking for participantsNCT07732491
What this trial is testing

Culmerciclib in HR+/HER2+ Advanced Breast Cancer

Who this might be right for
Breast CancerMetastastic Breast CancerHER2+ Advanced Breast Cancer
Sun Yat-sen University 35
Large-scale testing (Phase 3)Looking for participantsNCT05624996
What this trial is testing

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaStage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8
NRG Oncology 474
Early research (Phase 1)WithdrawnNCT07297160
What this trial is testing

CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors

Who this might be right for
LymphomaMyelomaSolid Tumors+2 more
Baylor College of Medicine
Not applicableStudy completedNCT04328103
What this trial is testing

Mechanisms of Emotion Regulation Underlying Successful CBT in Depression

Who this might be right for
Major Depressive Disorder
New York State Psychiatric Institute 41
Not applicableStudy completedNCT01360476
What this trial is testing

Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients

Who this might be right for
HypertensionLeft Ventricular Hypertrophy
Wayne State University 354
Large-scale testing (Phase 3)Study completedNCT00640991
What this trial is testing

REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)

Who this might be right for
HyperglycemiaCardiovascular DiseasesMyocardial Infarction
Population Health Research Institute 500
Large-scale testing (Phase 3)Study completedNCT04627896
What this trial is testing

Targeted Microwave Focal Therapy

Who this might be right for
Prostate Cancer Stage I
A.O.U. Città della Salute e della Scienza 11
Post-approval studies (Phase 4)Study completedNCT04485325
What this trial is testing

Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients

Who this might be right for
Rheumatic Arthritis
Dr. Frank Behrens 92
Next Page